{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:33:44Z","timestamp":1763058824825,"version":"3.41.2"},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vulnerable patient populations have seen decreased rates of vaccination against SARS\u2010CoV2\u201019 (COVID\u201019) due to hesitancies and distrust, magnified by a paucity of data for certain populations. The rate of COVID\u201019 vaccination in children with sickle cell disease (SCD) remains low despite the risk for severe complications, resulting in continued infections and hospitalizations from COVID\u201019. We sought to describe vaccine reactions, including vaso\u2010occlusive crises, emergency department visits, and hospitalizations, in children with SCD. Our findings will start to provide the necessary vaccine side effect data to inform patients, caregivers, and clinicians considering the COVID\u201019 primary vaccination series.<\/jats:p>","DOI":"10.1002\/pbc.30193","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T11:18:36Z","timestamp":1672399116000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Side effects following COVID\u201019 vaccination in pediatric patients with sickle cell disease"],"prefix":"10.1002","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-0395","authenticated-orcid":false,"given":"Jennifer A.","family":"Belsky","sequence":"first","affiliation":[{"name":"Department of Pediatrics Indiana University School of Medicine  Indianapolis Indiana USA"},{"name":"Division of Pediatric Hematology Oncology Riley Hospital for Children  Indianapolis Indiana USA"},{"name":"Marian University College of Osteopathic Medicine  Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney R.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Marian University College of Osteopathic Medicine  Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Feliciano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Indiana University School of Medicine  Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seethal A.","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Indiana University School of Medicine  Indianapolis Indiana USA"},{"name":"Division of Pediatric Hematology Oncology Riley Hospital for Children  Indianapolis Indiana USA"},{"name":"Center for Pediatric and Adolescent Comparative Effectiveness Research  Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009\u20101465"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24887"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.170"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003456"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004288"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006917"},{"key":"e_1_2_7_8_1","unstructured":"COVID\u201019 vaccines for people who are moderately or severely immunocompromised.CDC; updated2022. Accessed September 2 2022.https:\/\/www.cdc.gov\/coronavirus\/2019\u2010ncov\/vaccines\/recommendations\/immuno.html"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2010020\u20102798\u20103"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23627"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25390"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21026"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18443"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2022.2085072"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2048560"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24798"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2019.042"},{"key":"e_1_2_7_18_1","unstructured":"COVID\u201019 and sickle cell disease: frequently asked questions.American Society of Hematology; updated2021. Accessed September 2022.https:\/\/www.hematology.org\/covid\u201019\/covid\u201019\u2010and\u2010sickle\u2010cell\u2010disease"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.255398"},{"key":"e_1_2_7_20_1","unstructured":"FDA authorizes Pfizer\u2010BioNtech COVID\u201019 vaccine for emergency use in children 5 through 11 years of age.U.S Food and Drug Administration;2021. Accessed August 28 2022.https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010authorizes\u2010pfizer\u2010biontech\u2010covid\u201019\u2010vaccine\u2010emergency\u2010use\u2010children\u20105\u2010through\u201011\u2010years\u2010age"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107456"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1607"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003444"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29271"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.30193","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pbc.30193","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.30193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T23:50:33Z","timestamp":1692575433000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.30193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1002\/pbc.30193"],"URL":"https:\/\/doi.org\/10.1002\/pbc.30193","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"type":"print","value":"1545-5009"},{"type":"electronic","value":"1545-5017"}],"subject":[],"published":{"date-parts":[[2022,12,30]]},"assertion":[{"value":"2022-11-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e30193"}}